Understanding and combating mastitis in dairy animals
Imagine pouring thousands of dollars down the drain, one udder at a time. That's the reality dairy farmers face worldwide against a hidden adversary: mastitis.
This inflammatory condition represents the costliest disease affecting the global dairy industry, with estimated annual losses ranging between $19.7 and $32 billion 8 .
What makes mastitis particularly challenging is its dual nature—while some cases show visible symptoms, many infected animals harbor subclinical infections that silently drain profits.
Mastitis is an inflammatory condition of the mammary gland tissue, typically caused when pathogens invade the teat canal and multiply within the udder 6 . The most common culprits include Staphylococcus aureus, Escherichia coli, and various Streptococcus species 3 9 .
| Type | Visible Signs | Detection Method | Economic Impact |
|---|---|---|---|
| Clinical Mastitis | Clots, flakes, or discoloration in milk; swollen, hot, or painful udder | Visual observation during milking | Treatment costs, milk discard |
| Subclinical Mastitis | No visible changes in milk or udder | Specialized tests (CMT, SCC) | Reduced yield, lower quality, hidden transmission |
The subclinical form is particularly damaging—studies indicate approximately $200 in lost productivity per cow annually goes undetected without proper monitoring .
Subclinical mastitis represents a particularly insidious challenge for dairy operations. Unlike clinical cases with their obvious symptoms, subclinical infections offer no visible clues—the milk appears normal, the udder shows no swelling or redness, yet milk production steadily declines and milk composition changes for the worse 3 .
The primary indicator of subclinical mastitis is elevated somatic cell count (SCC). Somatic cells include white blood cells (leukocytes) and epithelial cells shed from the udder lining. While low levels are normal in all milk, a sharp increase signals the immune system is fighting an infection 1 .
70,000
cells/ml in uninfected quarters
The California Mastitis Test (CMT) provides a simple, cow-side method to estimate SCC. The test uses a reagent that lyses somatic cells, releasing DNA that causes the mixture to thicken or "gel" in proportion to the number of cells present 7 .
The reaction is scored on a scale from trace (negative) to +3 (strong positive), helping farmers identify infected quarters within minutes 7 .
Recent research has expanded this concept further. A 2023 study investigated whether commercially available domestic detergents from Ethiopia and Nigeria could effectively replace specialized CMT reagents in resource-limited settings 3 .
This innovation highlights the global effort to make mastitis detection more accessible and affordable for dairy producers everywhere.
Revolutionizing milk quality monitoring through advanced cell analysis
A 2025 study presented at the American Dairy Science Association's Annual Meeting delivered crucial insights into how combining traditional SCC with newer differential somatic cell count (DSCC) parameters could revolutionize milk quality monitoring 1 .
The DSCC measurement specifically identifies the percentage of lymphocytes and macrophages versus other somatic cells, providing a more nuanced picture of the inflammatory stage than total SCC alone 1 .
The findings revealed that the combination of elevated SCS (Somatic Cell Score) with lower proportions of DSCC was associated with the most substantial milk loss 1 .
| SCS Level | DSCC Percentage | Estimated Daily Milk Loss | Lactose Content |
|---|---|---|---|
| SCS 2 (Low) | 65% | Baseline (0 kg/d) | Normal |
| SCS 7 (High) | 55% | 1.45 kg/d | Lowest |
| SCS 7 (High) | Higher DSCC | Moderate loss | Moderate reduction |
The research demonstrated that DSCC provides valuable information about the stage and severity of inflammation that isn't apparent from SCC alone. This combination allows for more targeted management decisions, potentially helping farmers identify which animals require intervention.
Addressing a growing global threat in veterinary medicine
The growing challenge of antimicrobial resistance (AMR) among mastitis-causing pathogens has become a critical concern in veterinary medicine 9 . A 2025 nine-year retrospective study in Iran examining resistance patterns of major mastitis pathogens revealed alarming trends.
| Pathogen | Highest Resistance Antibiotic | Resistance Rate | Multidrug Resistance Rate |
|---|---|---|---|
| E. coli | Tylosin | 91.63% | 45.86% |
| S. agalactiae | Tylosin | 61.24% | 22.05% |
| S. aureus | Tylosin | 46.09% | 30.4% |
Farm size emerged as a significant factor, with larger farms associated with lower odds of multidrug resistance, highlighting how management practices influence resistance development 9 .
The study also found seasonal variations in resistance patterns, suggesting complex environmental factors at play 9 .
In response to these challenges, researchers are exploring alternative treatment approaches. A 2025 German study investigated using ketoprofen (a nonsteroidal anti-inflammatory drug) as initial treatment for non-severe mastitis, followed by antibiotics only in cases without clinical improvement 1 .
in antibiotic use with targeted NSAID-first approach
This approach demonstrates how targeted therapies can support antimicrobial stewardship while maintaining animal health 1 .
Modern mastitis management relies on a range of diagnostic tools that help identify infected animals and guide treatment decisions.
| Tool/Technique | Primary Function | Use Context | Advantages |
|---|---|---|---|
| California Mastitis Test (CMT) | Estimates somatic cell count | Cow-side screening | Quick, inexpensive, easy to interpret |
| Somatic Cell Count (SCC) | Measures inflammatory cells in milk | Laboratory or on-farm systems | Quantitative, reliable IMI indicator |
| Bacteriological Culture | Identifies specific pathogens | Laboratory diagnosis | Guides targeted treatment |
| Electrical Conductivity (EC) | Detects changes in milk composition | Automated milking systems | Continuous monitoring, non-invasive |
| Differential SCC (DSCC) | Identifies types of somatic cells | Advanced milk quality testing | Reveals inflammation stage |
Toward precision-based approaches and integrated health management
The battle against mastitis is evolving toward more precision-based approaches that combine advanced diagnostics with targeted interventions. Researchers are exploring everything from chitosan infusions to improve udder health to machine learning models that can predict infection risk based on multiple parameters 1 5 .
The One Health perspective—recognizing the interconnection between animal, human, and environmental health—is increasingly important in addressing mastitis 8 . This approach emphasizes responsible antimicrobial use, integrated surveillance systems, and management practices that benefit both animal welfare and farm profitability.
As dairy systems worldwide continue to evolve, the fight against mastitis will likely focus on prevention rather than treatment, leveraging data from automated milking systems, improved genetic selection, and vaccines that can reduce the incidence of new infections.
Mastitis remains one of the most significant challenges in dairy production, but the growing arsenal of detection methods and management strategies offers renewed hope for controlling this costly disease.
From the simple CMT paddle to sophisticated differential cell counting, the ability to identify and characterize infections has never been better.
As research continues to unveil the complex interactions between pathogens, host immunity, and management factors, dairy producers worldwide are increasingly equipped to safeguard both animal welfare and their economic viability.
The udder health revolution is underway—and it's looking brighter for farmers and cows alike.
References to be added manually in the designated section.